0001213900-21-034237 Sample Contracts

INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE SOMALOGIC, INC. 2021 OMNIBUS INCENTIVE PLAN
Incentive Stock Option Agreement • June 25th, 2021 • CM Life Sciences II Inc. • Services-commercial physical & biological research • Delaware

THIS INCENTIVE STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and

Sample 1Sample 2Sample 3See All (18)
AutoNDA by SimpleDocs
STOCK APPRECIATION RIGHTS AGREEMENT PURSUANT TO THE SOMALOGIC, INC. 2021 OMNIBUS INCENTIVE PLAN
Stock Appreciation Rights Agreement • June 25th, 2021 • CM Life Sciences II Inc. • Services-commercial physical & biological research • Delaware

THIS STOCK APPRECIATION RIGHTS AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and

Sample 1Sample 2Sample 3See All (15)
NON-QUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE SOMALOGIC, INC. 2021 OMNIBUS INCENTIVE PLAN
Non-Qualified Stock Option Agreement • June 25th, 2021 • CM Life Sciences II Inc. • Services-commercial physical & biological research • Delaware

THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and

Sample 1Sample 2Sample 3See All (6)
RESTRICTED STOCK AWARD AGREEMENT PURSUANT TO THE SOMALOGIC, INC. 2021 OMNIBUS INCENTIVE PLAN
Restricted Stock Award Agreement • June 25th, 2021 • CM Life Sciences II Inc. • Services-commercial physical & biological research • Delaware

THIS RESTRICTED STOCK AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and

Sample 1Sample 2Sample 3
MASTER COLLABORATION AGREEMENT by and between SomaLogic, Inc. and Novartis Pharma AG September 20, 2019
Master Collaboration Agreement • June 25th, 2021 • CM Life Sciences II Inc. • Services-commercial physical & biological research • New York

This Master Collaboration Agreement (the “Agreement”) is made effective as of the last date of signature set forth below (the “Effective Date”) between SOMALOGIC, INC., a Delaware corporation having its principal office ‘at 2945 Wilderness Place, Boulder, CO 80301 (“SomaLogic”), and Novartis Pharma AG, a Swiss company with its principal place of business at Lichtstrasse 35, Basel, Switzerland 4056 (“Novartis”). SomaLogic and Novartis may be referred to herein individually as a “Party” and together as the “Parties”. Capitalized terms set forth herein have the meanings set forth in the body of this Agreement or in Appendix 1 (Definitions).

Sample 1
RESTRICTED STOCK UNIT AWARD AGREEMENT PURSUANT TO THE SOMALOGIC, INC. 2021 OMNIBUS INCENTIVE PLAN
Restricted Stock Unit Award Agreement • June 25th, 2021 • CM Life Sciences II Inc. • Services-commercial physical & biological research • Delaware

THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and

Sample 1
CERTAIN IDENTIFIED INFORMATION, MARKED WITH “[****]”, HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDED AND RESTATED MASTER SOMASCAN® DISCOVERY...
Master Somascan Discovery Services Agreement • June 25th, 2021 • CM Life Sciences II Inc. • Services-commercial physical & biological research • New York

The following terms and conditions of this Amended and Restated Master SomaScan Discovery Services Agreement (“Agreement”), effective as of October 13, 2020 (the “Amendment Effective Date”), govern the services to be performed for AMGEN INC., a Delaware corporation with a business address at One Amgen Center Drive, Thousand Oaks, California 91320 (“Client” or “Amgen”), by SomaLogic, Inc., a Delaware corporation having its principal office at 2945 Wilderness Place, Boulder, CO 80301 (“SomaLogic”). SomaLogic and Client may be referred to herein individually as a “Party” and collectively as the “Parties.”

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!